Back to search

University of Ioannina

A study of the immune system in patients with chronic kidney disease and kidney transplant recipients: correlations with markers of cardiovascular disease

Abstract

dc:description

Cardiac remodeling is a hallmark of chronic kidney disease (CKD) manifesting as myocardial fibrosis, left ventricular hypertrophy (LVH), impaired myocardial strain and eventually left ventricular diastolic and systolic dysfunction. Kidney transplantation is associated with significant improvements in left ventricular size and function, as well as regression of LVH, otherwise known as reverse remodeling. Nevertheless, subclinical abnormalities in the biventricular strain may be observed in kidney transplant recipients (KTRs) even when other classical indices of myocardial function such as ejection fraction (EF) are normal. Maladaptive activation of the immune system plays an essential role in the pathogenesis of CKD and cardiovascular disease (CVD). The role of immune system components in the development of myocardial remodeling in CKD and kidney transplantation remains an open question. Likewise, little evidence has been generated until now regarding potential alterations of the cellular components of the immune system in patients with CKD due to heart failure, as occurs in type 2 cardiorenal syndrome (CRS-2). We therefore conducted a cross-sectional study in a cohort of non-end-stage CKD patients and KTRs without established CVD to investigate for the first time the relation of a selected panel of immune cell subpopulations in the peripheral circulation with classical and novel, strain-related indices of myocardial performance as evaluated by two-dimensional STE. In addition, we investigated the expression of a selected panel of immune cell subsets in the peripheral blood of a cohort of CRS-2 patients and subsequently made comparisons to a group of patients with CKD but without established CVD matched for gender and estimated glomerular filtration rate (eGFR). We further examined the clinical correlations as well as the prognostic value of specific immune cells with respect to overall and cardiovascular mortality in patients with type CRS-2. There were enrolled 44 consecutive patients with CKD and without established CVD, who were under regular follow-up by our outpatient nephrology clinic and 38 KTRs without established CVD who were under follow-up by the kidney transplant unit of our hospital as well as 39 stable male patients with CRS-2 under regular follow-up by the outpatient chronic heart failure and CKD clinic of our hospital. After baseline evaluation, patients with CRS-2 were followed until the end of the established observation period, or the study endpoint was reached, which was defined as a combined outcome of all-cause mortality and cardiovascular mortality.The peripheral blood immune cell subsets analysis was performed by flow cytometry. Accordingly, CD14++CD16-, CD14++CD16+, and CD14+CD16++ percentage and the absolute number of cells out of the total monocytes, as well as NK cells (CD3+CD16+56+), CD3- CD19+ B-lymphocytes, CD3+ CD4+ T cells, CD3+CD8+ T cells, and T regulatory cells (Tregs) (CD4+CD25+ FoxP3+) absolute values, and percentage out of the total lymphocytes were measured. Anthropometric and clinical data were recorded at baseline by patients’ medicalrecords, including comorbidities such as the presence of diabetes mellitus (DM) and medications. In addition, common biochemical parameters were measured at baseline in accordance with standard methods applied in the hospital laboratory. Echocardiographic data from ultrasounds performed by a skilled operator within 1 month from immune cell subset analysis were recorded, including parameters for estimating ventricular function and morphology and for cardiac chamber quantification. Specifically, regarding CKD patients and KTRs, classical and novel strain-related indices of ventricular function were measured by speckle-tracking echocardiography at baseline and following dipyridamole infusion. Two-dimensional STE analysis included assessment of global longitudinal strain (GLS), global radial strain (GRS) and global circumferential strain (GCS). In addition, left ventricular twist and untwist rates were measured. Following the baseline echocardiographic evaluation, dipyridamole was administered, and a new echocardiographic assessment was performed. The differences (Δ) between the values of measured echocardiographic parameters post and prior to dipyridamole infusion were calculated. Following adjustment for confounders including age, eGFR and UPCR, the differences in immune cell subsets between CKD patients and KTRs remained statistically significant for the percentage of classical monocytes (p =0.02, both the number and percentage of non-classical monocytes (p < 0.001), the percentage of T-lymphocytes and B lymphocytes (p = 0.03 and p = 0.003, respectively) as well as the Tregs number (p = 0.008). Following univariate regression analysis, the differences in immune cell subsets between patients with CRS-2 and CKD patients remained statistically significant for CD14++CD16+ monocytes, total lymphocytes, and NK cells (p < 0.05 for all) but not for Tregs, after adjustment for various confounders including age. Interestingly, we found increased levels of proinflammatory intermediate CD14++CD16+ monocytes in CRS-2 patients as compared to CKD patients, albeit no significant differences were detected between other robust markers of inflammation, such as CRP or ESR between the two cohorts. Our results showed lower levels of NK cells in patients with CRS-2 compared to their CKD counterparts as well as in CRS-2 patients with chronic atrial fibrillation compared to those without. In CKD patients, a direct association of RWT, a measure of left ventricular concentricity broadly used as an index of LVH with CD14++CD16− monocytes count (β = 0.447, p = 0.004) was found, whereas the correlation with arterial hypertension was lost at multivariate analysis. Furthermore, in KTR, the classical CD14++CD16− monocytes count was inversely associated with improvements in systolic wall motion indices, such as the medial and lateral wall systolic velocity of the left ventricle (Sl and Sm) (β = −0.516, p = 0.01 and β = −0.707, p < 0.001, respectively). An interesting finding of the study is the trend of independent correlations between the intermediate CD14++CD16+ monocytes with strain-related left ventricular myocardial performance indices, both in CKD patients and in KTRs. Thus, the CD14++CD16+ monocyteswere independently associated with higher baseline GRS values in CKD patients, whereasin KTRs, they were associated with better baseline left ventricular twist (β = 0.416, p = 0.01) and untwist parameters (β = −0.742, p = 0.09). About our results, another potential explanation, though speculative, would be that a compensatory augmentation in strain-related myocardial performance indices is promoted in the setting of the microinflammatory milieu of CKD, which would subsequently lead to myocardial damage and remodeling. The results are thought provoking and merit additional research considering the complex properties of the pro-inflammatory CD14++CD16+ monocytes in the pathogenesis of myocardial remodeling in CKD and following kidney transplantation. It is worth mentioning that among our patients, KTRs displayed a higher classical CD14++CD16− monocytes count together with a lower level of pro-inflammatory CD14++CD16+ monocytes compared to the CKD patients, which is in line with data from previous studies. A negative correlation was found between CD4+ T-cells with left ventricular EF in CKD patients (β = −0.431, p = 0.009) as well as with the dipyridamole induced improvement of left ventricular EF in KTRs (β = −0.378, p = 0.02). Likewise, in KTRs we found a negative correlation of CD4+ T-cells both with MAPSE (β = −0.463, p = 0.04), a sensitive marker of early systolic dysfunction and TAPSE, a marker of right ventricular function, although the latter was lost following multivariate analysis. In accord with the above, about strain-related indices of left ventricular function, CD4+ T-cells were inversely correlated with dipyridamole induced improvements in GLS in KTRs (β = 0.403, p = 0.01). Further characterization of the CD4+ T-cell responses is needed in order to discern possible pathogenic links to the development of uremic cardiomyopathy, evaluate their role as novel biomarkers of disease and subsequently examine the effects of immunomodulation on the CKD-related myocardial remodeling.An independent association of CD8+ T-cells with both left ventricular twist and untwist in patients with CKD was found (β = 0.405, p = 0.02 and β = −0.363, p = 0.03 respectively). Considering the differences in the pathogenic models implemented by the above studies as well as the preliminary nature of our results, it remains to be determined whether CD8+ T-cells are simple bystanders or active and independent players in the mechanisms of CKD-related myocardial dysfunction. Interestingly, we detected an independent correlation of NK cells both with E/A ratio (β = −0.387, p = 0.02) as well as with GLS (β = −0.362, p = 0.01) in KTRs only. These results appear controversial at first sight considering that a physiological reduction in E/A ratio is observed with aging, whereas the relationship of this index with left ventricular diastolic function is more complex and should be evaluated in combination with other markers, including the E/E’ ratio. On the other hand, we also found that higher NK cell counts were associated with improved left ventricular strain in KTRs. Results of the prospective arm of the study regarding patients with CRS-2 showed that during a median follow-up of 29.8 ±3.4 months, 23 CRS-2 patients (59%) reached the study endpoint with no patients being lost to follow-up. At binary logistic regression analysis, immune cell subpopulations that correlated with all-cause and cardiovascular death included total lymphocyte counts, (OR 0.85 per 100 cells/μL increase; 95% CI 0.75–0.97; p = 0.01), T-cell number (OR 0.82 per 100 cells/μL increase; 95% CI 0.70–0.96; p = 0.01), CD4+ T-lymphocyte number (OR 0.66 per 100 cells/μL increase; 95% CI 0.50–0.87; p = 0.004), CD8+ T-lymphocyte counts below their median value cut-off of 410/μL (OR 4.67; 95% CI 1.14–19.07; p = 0.03), Treg counts below their median value cut-off of 35/μL (OR 6.63; 95% CI 1.36–23.27; p = 0.01), and CD14++CD16+ monocyte counts above their median cut-off value of 40/μL (OR 4.13; 95% CI 1.06–16.1; p = 0.04). In a multivariate model including all six immune cell subsets, only the CD4+ T-lymphocytes remained independent predictors of mortality (OR 0.66; 95% CI 0.50–0.87; p = 0.004). In contrast, no such associations were found for age, eGFR, UPCR, hsTnI, BNP, as well as the rest of the clinical or laboratory indices. Subsequently, Kaplan–Meier survival curves for CRS-2 patients according to the levels of immune cell subpopulations (i.e., below vs. above median value) were generated. Decreased levels of lymphocytes, T-lymphocytes, CD4+ T-cells, CD8+ T-cells, and Tregs were associated with mortality at a median follow-up of 30 months (p < 0.05 for all log-rank tests). Increased levels of proinflammatory intermediate CD14++CD16+ monocyte counts showed a trend for increased mortality (p = 0.093). Overall, this study provides preliminary but noteworthy evidence regarding the independent associations of immune cell subsets, including classical CD14++CD16 and intermediate CD14++CD16+ monocytes, NK cells and lymphocytes subsets independently correlate with subclinical indices of myocardial dysfunction, including left ventricular strain and torsion-related parameters, in patients with CKD and in KTRs without established CVD. Taking into consideration that subtle alterations in left ventricular function commence early in CKD, these findings provide novel insights suggesting a potential role for specific immune cell phenotypes for CKD-related cardiomyopathy. Notably, the CD4+ T-lymphocytes were shown to independently predict fatal cardiovascular events in patients with CRS-2. Furthermore, the study results showed that patients with CRS-2 exhibit alterations of the immune cell subsets profile in the circulation compared to CKD patients of similar kidney function but without established cardiovascular disease, thus indicating that distinct immune mechanisms might be involved in the pathogenesis or during the chronic clinical course of CKD in the setting of heart failure as compared to CKD without established CVD.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Ntouni, Anila
  • Ντούνι, Ανίλα

Subjects

dc:subject × 32

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/60285

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Ntouni, Anila; Ντούνι, Ανίλα. A study of the immune system in patients with chronic kidney disease and kidney transplant recipients: correlations with markers of cardiovascular disease. University of Ioannina, 2025. http://hdl.handle.net/10442/hedi/60285